Population Pharmacokinetics and Pharmacodynamics of Ciclesonide
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Ciclesonide is a novel glucocorticoid that is converted into ciclesonide—active principle (CIC‐AP) in the lung. The study objectives were to identify a structural model for population pharmacokinetic (PK) analysis of CIC‐AP using nonlinear mixed‐effects modeling, assess the influence of select covariates on PK and/or pharmacodynamic (PD) parameters, and investigate the effects of CIC‐AP on endogenous cortisol. Pooled concentration data from nine phase I studies (dose: 400–3600 μg) involving healthy and asthmatic patients were included in the PK analysis. There were 151 subjects (3300 observations) for the CIC‐AP population PK analysis. Various models examined inter‐ and intrasubject variability for the PK parameters. Population estimates of the PK parameters of clearance and volume of distribution were 396 L/h (64.8% coefficient of variation [CV]) and 1190 L (41.2% CV), respectively. Pharmacodynamic population estimates included maximum cortisol release rate, 3140 ng/h (5.4% CV). The EC50 of CIC‐AP was 0.88 ng/mL. Ciclesonide is a safe corticosteroid that causes negligible cortisol suppression. The disposition and effect of CIC‐AP can be described using mixed‐effect modeling. The estimated EC50 is similar to mean Cmax from an 800–μg dose, further suggesting CIC‐AP has little effect on cortisol suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918 · cited 9×
“Model 3 Does weight affect TVKA = θ (1) –9724 Yes the volume of TVCL = θ (2) distribution (V2) TVV2 = θ (3) + θ (4)*(WT/75)”
BackgroundInfluentialHypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy
Chrousos, G. P., & Harris, A. G. (1998) · Neuroimmunomodulation · doi:10.1159/000026349 · Cited by 48
Cited by
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma
Derendorf, H., Nave, R., Drollmann, A., Cerasoli, F., & Wurst, W. (2006) · European Respiratory Journal · doi:10.1183/09031936.00074905 · Cited by 253
Self-citationGlucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Ahmet, A., Kim, H., & Spier, S. (2011) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-7-13 · Cited by 114
Gulliver, T., Morton, R., & Eid, N. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709030-00007 · Cited by 47
Inhalational steroids and iatrogenic Cushing's syndrome
A.V, R. (2014) · The Open Respiratory Medicine Journal · doi:10.2174/1874306401408010074 · Cited by 17
“(99%) their systemic side-effects and adrenal suppression are minimal [36, 37].”
Background
Metadata
- Authors
- Rohatagi, S., Arya, V., Zech, K., Nave, R., Hochhaus, G., Jensen, B. K., & Barrett, J. S.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2003-04
- Volume
- 43
- Issue
- 4
- Pages
- 365-378
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2155318134
- Cited by
- 105
- References
- 2
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.